Balyasny Asset Management »

Relmada Therapeutics shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Relmada Therapeutics (RLMD) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Relmada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Relmada Therapeutics held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Relmada Therapeutics by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.6M 548k 4.83
2024-03-31 $57k 12k 4.65
2022-09-30 $11M 307k 37.02
2022-06-30 $4.5M 239k 18.99

More positions owned by Balyasny Asset Management

Invesco Qqq Tr Unit Ser 1 (QQQ)
Amazon Call Option (AMZN)
NVIDIA Corporation Call Option (NVDA)
Microsoft Corporation Call Option (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
Tesla Motors Call Option (TSLA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Select Sector Spdr Tr State Street Fin (XLF)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Apple Call Option (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Vaneck Etf Trust Semiconductr Etf (SMH)
Broadcom Put Option (AVGO)
Taiwan Semiconductor Mfg Sponsored Ads Call Option (TSM)

View all positions for Balyasny Asset Management

Top funds holding Relmada Therapeutics

Adage Capital Partners GP
Marshall Wace
Ikarian Capital
OrbiMed Advisors
Ameriprise Financial
Driehaus Capital Management
Millennium Management
Braidwell
BlackRock
Vanguard Group
Opaleye Management
Geode Capital Management
Boothbay Fund Management
CI Private Wealth
Two Sigma Investments

View all funds holding Relmada Therapeutics